Status:
COMPLETED
Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2
Lead Sponsor:
AstraZeneca
Conditions:
Upper-GI Symptoms
Eligibility:
All Genders
18+ years
Brief Summary
The current epidemiological study will be undertaken in GP's and specialized private doctors. In total, 85 general practitioners, orthopedics, rheumatologists and cardiologist will take part in the st...
Eligibility Criteria
Inclusion
- Acetylsalicylic acid/NSAIDS intake for at least 5 days of a week during the past month before the patient's visit to the clinician
Exclusion
- Patients who are not willing to sign of the Informed Consent Form
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT00691743
Start Date
March 1 2008
End Date
December 1 2008
Last Update
January 12 2009
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Agrinio, Greece
2
Research Site
Alexandroupoli, Greece
3
Research Site
Argostoli, Greece
4
Research Site
Athens, Greece